DIA/Tufts CSDD Research: AI Saving Time in Drug Development
DIA and the Tufts Center for the Study of Drug Development (Tufts CSDD), in collaboration with 16 biopharmaceutical companies and CROs, conducted a study to map current use of and experience with arti...
17 Tammi 202511min
DIA: Your Partner in Life Sciences Training and Development
This podcast by the Drug Information Association (DIA) highlights the significant benefits of investing in professional development programs for employees in the life sciences industry. They emphasiz...
6 Marras 202414min
DIA: Going Beyond the Traditional Definition of Drug Development
In this DIA 60th anniversary interview, former Board President Ling Su shares his thoughts on the two most important aspects of DIA’s future for the next generation of members.
29 Touko 20241min
GPP Experts Explain Authorship Algorithm
Good Publication Practice (GPP) experts explain the authorship algorithm designed to weigh each author's contribution relative to other authors' contributions in a study, and to define appropriate way...
23 Huhti 20247min
"Dossier in the Cloud" Democratizing Global Access
Accumulus Synergy CEO Francisco Nogueira shares expectations for the outcomes of a post-approval changes pilot led by Roche which utilizes the Accumulus platform and follows WHO principles of good reg...
2 Huhti 20242min
Autumn’s Leukemia Story: Regimens, Recovery, and Realizations
A few years ago, 8-year-old Autumn noticed a lump on the side of her neck as she was preparing for bed one night. That quiet night opened a new chapter not only in Autumn’s life but in the life of her...
4 Joulu 202319min
Retiring TGA Head Maps Australia’s Post-Pandemic Future
In April 2023, Professor John Skerritt retired after 11 years of exemplary public service as deputy secretary of the Health Products Regulation Group and head of the Therapeutic Goods Administration i...
17 Heinä 202318min
